118 related articles for article (PubMed ID: 6440736)
1. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
Shaaban MM; Elwan SI; el-Sharkawy MM; Farghaly AS
Contraception; 1984 Nov; 30(5):407-12. PubMed ID: 6440736
[TBL] [Abstract][Full Text] [Related]
2. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
3. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
Shaaban MM; Elwan SI; Abdalla SA; Darwish HA
Contraception; 1984 Nov; 30(5):413-9. PubMed ID: 6440737
[TBL] [Abstract][Full Text] [Related]
4. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
5. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Berenson AB; Wiemann CM
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
[TBL] [Abstract][Full Text] [Related]
6. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
7. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
Biswas A; Biswas S; Viegas OA
Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
[TBL] [Abstract][Full Text] [Related]
8. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
Singh K; Viegas OA; Loke DF; Ratnam SS
Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
[TBL] [Abstract][Full Text] [Related]
9. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
10. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
[TBL] [Abstract][Full Text] [Related]
12. Serum bile acids during biphasic contraceptive treatment with ethinyl estradiol and norgestrel.
Heikkinen J; Ylöstalo P; Mäentausta O; Jänne O
Contraception; 1982 Jan; 25(1):89-95. PubMed ID: 6800694
[TBL] [Abstract][Full Text] [Related]
13. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
14. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
15. Effect of Norplant on liver function.
Chowdhury TA; Khan M; Chowdhury S; Rashid M; Banu LP; Ali S
Bangladesh Med Res Counc Bull; 1998 Apr; 24(1):10-3. PubMed ID: 9776869
[TBL] [Abstract][Full Text] [Related]
16. Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis.
Toppozada M; Amer S; el-Ghazzawi E
Adv Contracept; 1986 Jun; 2(2):117-22. PubMed ID: 3096090
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
Koopersmith TB; Lobo RA
Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
[TBL] [Abstract][Full Text] [Related]
18. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
Dash DS; Das S; Nanda U; Tripathy BB; Samal KC
Contraception; 1988 Apr; 37(4):371-82. PubMed ID: 3133159
[TBL] [Abstract][Full Text] [Related]
19. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraception on serum bile acid.
Shaaban MM; Ghaneimah SA; Mohamed MA; Abdel-Chani S; Mostafa SA
Int J Gynaecol Obstet; 1984 Apr; 22(2):111-5. PubMed ID: 6145634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
